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Abstract
Background and Purpose: Little is known about the associations of post-stroke fatigue or its influence on survival. The
vitality component of the Short Form 36 (SF-36) is a valid and reliable measure of post-stroke fatigue. We sought to identify
associates of post-stroke fatigue and determine whether fatigue predicted survival.
Methods: We used SF-36 vitality scores obtained by postal questionnaires from 1080 UK patients randomised in the
International Stroke Trial, at a mean of 64 weeks after stroke onset. We used logistic regression to explore factors at
randomisation which predicted SF-36 vitality at follow-up, and the relationship between SF-36 vitality and both SF-36
mental health and SF-36 emotional role function at follow-up. We used Cox proportional hazards to explore the influence of
SF-36 vitality at follow-up on subsequent survival, using four different statistical models for handling missing data.
Results: Female sex, increasing age, lower mental health and lower emotional role function scores were associated with
greater degrees of fatigue after stroke (i.e. lower vitality scores) but these factors explained ,30% of the variance (R2) in
fatigue. In two models, fatigue at follow-up was associated with shorter subsequent survival.
Conclusion: Increasing age, female sex, emotional role function and mental health were associated with increased fatigue at
a mean of 64 weeks after stroke onset, but explained less than 30% of the variance. Fatigue was associated with reduced
subsequent long-term survival in 2/4 models. Further work is needed to identify the biological substrate of fatigue and to
clarify its influence on survival.
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Introduction
Fatigue is common after stroke, with estimates of prevalence
ranging from 16% [1] to 70% [2]. Fatigue is one of the most
distressing symptoms after stroke [3], yet its aetiology remains
uncertain. In the general non-stroke population, fatigue is often a
symptom of depression. Several cross-sectional studies [1,3-8] and
one longitudinal study [9] have sought associations of fatigue
after stroke using different generic fatigue scales. Most [1,3,4,6,9]
but not all [7,8] have found associations with depression. One
previous study found an association with variability in blood
pressure [10]. Early studies of fatigue after stroke suggested that it
is more common in brain stem lesions [7], but other studies have
not shown such an association [1,4,6,8,9,11,12]. The single
previous study that investigated associations between fatigue and
survival found that it was independent predictor of shorter
survival [1].
All previous studies of fatigue after stroke used generic fatigue
scales which had not been tested for validity or reliability in stroke.
The vitality domain of the Short-Form 36 (SF-36) has face validity
and is reliable after stroke [12], and correlates with other fatigue
scales [11]. Stroke patients fulfilling a case definition for clinically
significant fatigue have lower SF-36 vitality scores than those
without clinically significant fatigue [12].
The vitality domain in the original version of the SF-36 includes
four questions: In the past four weeks: ‘Did you feel full of pep?’,
‘Did you have a lot of energy?’, ‘Did you feel worn out?’ and ‘Did
you feel tired?’ Responses to each question are: ‘All of the time’,
‘Most of the time’, ‘a Good bit of the time’, ‘Some of the time’ ‘A
little of the time’ and ‘None of the time’ [13]. After the responses
to the individual questions were recorded, a total score for vitality
can be calculated according to the SF-36 scoring manual [13].
The range of possible scores is from 0 to 100, with higher scores
indicating higher vitality (i.e. less fatigue).
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Our aims were to determine: a) what factors at stroke onset
predicted SF-36 vitality scores [13] measured a few months later,
b) the relationship between SF-36 vitality measured in survivors a
few months after stroke and mood (SF-36 mental health domain
and emotional role function domain) and c) influence of SF-36
vitality in survivors on subsequent survival.
Materials and Methods
We used data from patients in the International Stroke Trial
(IST), recruited by UK Centres, who had participated in a
substudy on quality of life after stroke [14-17].
The International Stroke Trial
The IST was a randomised controlled trial of the effects
of aspirin, subcutaneous heparin, both or neither, among
19,435 patients with acute ischaemic stroke, recruited within
48 hours of stroke onset [17]. To receive the patient’s ran-
domised treatment allocation, clinicians telephoned a central
randomisation service. During this telephone call, after data on
age, gender, pathological subtype of stroke, stroke subtype,
neurological deficits, blood pressure and cardiac rhythm had
been recorded and checked, the system generated the treatment
allocation [17].
Collection of SF-36 data
A subset of the patients recruited by the UK centres in the IST
trial participated in a study of quality of life after stroke. Surviving
patients (n = 2253) were sent either a SF-36 or EuroQUOL
(another scale to measure quality of life) by postal questionnaire
[14-16] at a mean of 64 (SD 30) weeks following randomisation.
Between 2nd March 1993 and 31st May 1995, 1400 patients were
sent a SF-36, of whom 1080 responded (77%) [14-16]. The SF-36
includes the following domains: vitality, physical functioning,
physical role function, social functioning, bodily pain, mental
health, emotional role functioning and general health [13-16].
Each domain, including the mental health and emotional role
function domains, includes several questions. We changed the
question ‘Did you feel full of pep?’ to ‘Did you feel full of life?’ to
ensure its cultural relevance [13-15]. The responses to the
questions allow a total score for each domain to be calculated
using the standardised SF-36 scoring manual [13]. Scores for each
domain range from 0-100, with higher scores indicating better
health.
These data allowed us to explore the relationship between SF-
36 vitality a few months after stroke, patient characteristics at
randomisation and the SF-36 role emotional and SF-36 mental
health a few month after stroke.
Collection of survival data
All UK patients in IST were ‘flagged’ at the Office for National
Statistics central registry of deaths, enabling us to collect data on
all deaths occurring in this cohort up to November 2000 giving us
survival data for between 5 and 7 years after the assessment of SF-
36 [18].
Statistical analysis of factors at randomisation associated
with fatigue on follow-up
We analysed fatigue severity (SF-36 vitality) as a continuous
variable. We performed multiple linear regression analyses to
determine the relationship between fatigue and the following
variables measured at randomisation: age, gender, pathological
subtype of stroke (ischaemic, haemorrhagic or indeterminate),
stroke subtype (total anterior circulation syndrome (TACS), partial
anterior circulation syndrome (PACS), lacunar syndrome (LACS),
posterior circulation syndrome (POCS) or ‘other’), presence of a
visible infarct on brain imaging, cardiac rhythm (atrial fibrillation
or sinus rhythm) and systolic blood pressure (,140, 140-159, 160-
79, .180mmHg.
Results were reported in the form of regression equations.
For a simple linear regression, with one predictor variable, the
equation would be of the form Y= a+b*X i.e. the Y variable
can be expressed in terms of a constant (a) and a slope (b)
multiplied by the X variable. For multiple linear regression
analysis when there is more than one independent variable (as
in this study), the regression line cannot be visualized in the
two dimensional space, but can be computed using a linear
equation containing all those variables. Multiple regression
procedures estimate a linear equation of the form: Y= a+b1*
X1+b2*X2+…+bp*Xp.
We performed four sensitivity analyses to determine the
robustness of the estimates to different assumptions about missing
data, in which we: i) removed those with missing vitality data ii)
imputed the minimum value recorded iii) imputed the maximum
value recorded iv) imputed the mean value observed.
Statistical analysis of association between mood and
fatigue
At follow-up, patients completed the emotional role score and
the mental health scores of the SF-36. The responses were used to
calculate a total score for each domain [13], ranging from 0-100,
with higher score indicating better health.
We produced multiple regression models which included the
variables at randomisation shown to have an effect on vitality score
(i.e. the final models generated in the previous section) and the SF-
36 mental health and SF-36 emotional role scores. Missing scores
for emotional role function and mental health were treated in the
same way as missing scores for vitality.
Statistical analysis of the influence of fatigue at follow-up
on subsequent survival
We generated a Cox proportional hazards model containing
the following variables: age, sex, pathological subtype, stroke
subtype, visible infarct, atrial fibrillation (at randomisation),
systolic blood pressure (at randomisation) and all component
parts of the SF-36 at follow-up (vitality, role-emotional,
mental health, physical function, bodily pain, general health
and social function) with the exception of role-physical. We did
not include role-physical as this measures similar constructs to
physical function and there were more missing values for role
physical than for physical function. For these analyses, survival
was measured from the date on which SF-36 vitality was
measured.
Where the initial model generated contained variables which
did not reach statistical significance at the 5% level, we removed
the least significant variable and generated a new model. We
repeated this process until the only variables remaining in the
model were those which reached statistical significance. We
calculated four different models to explore robustness to differing
assumptions about missing variables.
Using the threshold value of at least ‘10 patients per variable’
rule for the analyses of regression, we had sufficient power for our
analyses [19].
Results
The mean age of the participants was 71.1 (SD 10.8) years
and 602 (55.7%) were men. Other demographic details are
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shown in table 1. Median SF-36 vitality score (inter-
quartile range) was 37.5 (20.0, 55) for the entire group, 40
(IQR 25, 55) for men and 35 (20,50) for women. The
distribution of the vitality scores for men and women is shown
in figure 1.
Baseline predictors of fatigue
We analysed SF-36 data from 1080 patients, of whom 1006
(93%) had a vitality score recorded. The amount of variability in
the vitality score explained by the variables we included was very
small [adjusted R2 values for the 4 models were: 0.037, 0.054,
0.004, 0.034 respectively].
Three of the four final multiple regression models contained the
same variables although the parameter estimates varied slightly.
However, when the missing values were set to the maximum
recorded value, the model was very different, with only gender
predicting fatigue. These equations allow us to estimate SF-36
vitality score if we have data for age, gender, pathological type
(ischaemic, haemorrhagic or indeterminate), and subtype (TACS,
PACS, LACS, POCS or ‘other’ stroke subtype).
Each of models is specified in full below, according to how
missing data were dealt with:
a) Missing values excluded
SF-36 vitality~64:21{0:22  (age)z4:71(if male){
12:48(if ischaemic){10:09(if haemorrhagic){
9:53(if indeterminate)z1:31(if POCS){
5:65(if TACS){0:97(if LACS){
11:13(if other stroke subtype)
Figure 1. Distribution of SF-36 vitality scores, according to gender. Higher vitality scores indicate less fatigue.
doi:10.1371/journal.pone.0016988.g001
Table 1. Baseline characteristics of the 1080 participants.
Characteristic Number %
Sex Male 602 55.7
Stroke type Ischaemic 918 85.0
Haemorrhagic 82 7.6
Indeterminate 53 4.9
Not stroke 27 2.5
Stroke sub-type LACS 285 26.4
PACS 446 41.3
POCS 124 11.5
TACS 222 20.6
Other 3 0.28
Infarct visible Yes 265 24.5
Atrial fibrillation Yes 166 15.4
Systolic blood pressure ,140 200 18.5
140 - 159 306 28.3
160 - 179 273 25.3
.= 179 301 27.9
doi:10.1371/journal.pone.0016988.t001
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b) Missing values set to minimum
SF-36 vitality~69:65{0:32  (age)z4:79(if male){
13:76(if ischaemic){10:59(if haemorrhagic){
8:97(if indeterminate)z1:16(if POCS){
6:44(if TACS)z0:73(if LACS){
9:34(if other stroke subtype)
c) Missing values set to maximum
SF-36 vitality~40:23z3:65(if male)
d) Missing values imputed at mean
SF-36 vitality~62:74{0:22  (age)z4:29(if male){
11:89(if ischaemic){9:79(if haemorrhagic){
9:15(if indeterminate)z1:13(if POCS){
5:17(if TACS){0:93(if LACS){
10:78(if other stroke subtype)
Note: ‘Other’ stroke syndrome is defined as those individuals
whose clinical syndromes could not be assigned to one of the four
OCSP syndromes.
Association between mood and fatigue
We determined association between mood and fatigue, using SF-
36 mental health scores, SF-36 emotional role scores and vitality
scores. There were missing data from 6.7% of mental health scores
and 18.3% of emotional role scores. Figure 2 shows the univariate
relationship between SF-36 mental health and vitality (Pearson
correlation coefficient 0.20, p,0.001, n= 1004). Figure 3 shows the
univariate relationship between SF-36 role emotional and vitality
(Pearson correlation coefficient 0.38, p,0.001, n= 863).
For the multiple logistical regression models, gender, age,
mental health score and emotional role function were significant
predictors of vitality in all four models. The amount of variability
in the vitality score explained by variation in the models is small
[adjusted R2 for the 4 models are: 0.18, 0.29, 0.27, 0.16
respectively]. However, these models explain much more of the
variance than those models which did not include mental health
and emotional role scores.
The regression equations for all 4 models are shown below.
a) Missing values excluded
SF-3SF-36 vitality~32:24{0:23  agez3:79(if male)z
0:24  (mental health score)z0:18  (emotional role score)
b) Missing values set to minimum
SF-36 vitality~30:95{0:25  agez3:34(if male)-
7:58(if ischaemic)-5:44(if haemorrhagic)-
2:60(if indeterminate)z0:40  (mental health score)z
0:17  (emotional role score)
c) Missing values set to maximum
SF-36 vitality~4:48{0:18  agez
0:70  (mental health score)z0:13  (emotional role score)
d) Missing values imputed at mean
SF-36 vitality~30:52-0:21  (age)z3:14(if male)z
0:24  (mental health score)z0:18  (emotional role score)
(‘*’ means multiply)
Influence of fatigue on subsequent survival
Survival data to November 2000 were available for 1072/1080
(99.3%) participants, of whom 420/1072 (39.2%) had died. The
median number of days’ follow-up from randomisation to
November 2000 was 5.9 years (IQR 3.8 to 6.6). The median
length of follow-up from when SF-36 was measured, in the 1016
participants with this information recorded, was 5.2 years (IQR
2.4 to 5.3).
Table 2 presents multivariate analyses showing independent
predictors of survival. Increasing age, atrial fibrillation (at
randomisation) and ‘other’ stroke subtype predicted shorter
survival in all four models. In two models, higher SF-36 vitality
at follow-up predicted longer subsequent survival.
Discussion
To our knowledge, this is the first study to explore not only the
factors at stroke onset that predict post-stroke fatigue, but also the
relationship between fatigue and mood, and the influence of
fatigue at follow-up on subsequent survival. Increasing age, worse
emotional role function and worse mental health score measured
at follow-up were significantly associated with fatigue. Fatigue on
follow-up was associated with significantly reduced subsequent
survival in two models. Although we did not specifically aim to
compare SF-36 vitality scores after stroke with a general
population, we noted that the median SF-36 vitality score of
37.5 was substantially lower than the mean SF-36 vitality score of
55.8 from the general population aged 70-74 years [20].
The study had several strengths: it was a very large, prospective
and conducted in a single, well characterised cohort of stroke
patients recruited at a uniform time point (stroke onset); it used a
valid and reliable measure of fatigue after stroke (SF-36 vitality
score) [11,12]. It explored baseline predictors of fatigue,
relationship between fatigue and mood, and the influence of
fatigue on survival in the same large group of patients.
Increasing age, lower emotional role function and lower mental
health score were significantly associated with fatigue in all four
models and female sex was also significant in three models.
Importantly, the factors we identified accounted for only a small
amount of variance in fatigue, suggesting that other factors, for
which we did not collect data, must also be associated with
fatigue.
Previous cross-sectional studies have explored the relationship
between fatigue and mood disorders after stroke, with most but not
all finding associations. Thus, the evidence points to an association
between fatigue and mood disorders. However, we cannot
determine direction of causality from current evidence i.e. whether
fatigue causes mood disorders or whether mood disorders cause
Post-Stroke Fatigue in International Stroke Trial
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Figure 2. Relationship between SF-36 mental health and vitality. Higher scores indicate better health status. As the number of data points
are limited, a small random component (‘jitter’) has been added to each variable to better demonstrate the number of patients at a single co-
ordinate. (Pearson correlation coefficient 0.20, p,0.001, n = 1004).
doi:10.1371/journal.pone.0016988.g002
Figure 3. Relationship between SF-36 role emotional and vitality. Higher scores indicate better health status. As the number of data points
are limited, a small random component (‘jitter’) has been added to each variable to better demonstrate the number of patients at a single co-
ordinate. (Pearson correlation coefficient 0.38, p,0.001, n = 863).
doi:10.1371/journal.pone.0016988.g003
Post-Stroke Fatigue in International Stroke Trial
PLoS ONE | www.plosone.org 5 March 2011 | Volume 6 | Issue 3 | e16988
fatigue. In the general population, SF-36 vitality scores are lower
in women than men, and fall with increasing age [20], and fatigue
is a well-recognised symptom of mood disorders. Thus, these
findings are consistent with findings from the general population.
The extent to which the post-stroke vitality scores might have
been explained by pre-stroke scores is uncertain. One previous
study found that 62% of patients with post-stroke fatigue had had
pre-stroke fatigue [4], suggesting that some fatigue was present
before the stroke and that some develops after the stroke.
After correction for role emotional and mental health, we found
no evidence of a relationship between OCSP stroke subtype, as an
indicator of stroke lesion location and size, and fatigue. Ours is the
largest study to date to explore associations between fatigue and
stroke lesion location and size, and so this is an important negative
finding. Two previous studies have suggested that fatigue is more
common in brain stem strokes [5,7], although other studies did not
find an association between brain stem strokes and fatigue.
Although fatigue may not be related to lesion location, it is,
nevertheless, possible that fatigue may have a ‘central’ origin i.e. it
might be a direct consequence of a cerebral infarct or cerebral
haemorrhage [21]. The observation that fatigue after stroke is
unlike anything ever experienced before by stroke survivors [22]
supports the idea that fatigue might be directly caused by the brain
lesion.
One study has suggested that fatigue may be related to
dysregulation of blood pressure after stroke, perhaps as a result
of antihypertensive drugs [10]. We did not find an association
between baseline blood pressure and fatigue, but were unable to
explore relationship between fatigue and current blood pressure.
Intriguingly, lower SF-36 vitality scores (i.e. more fatigue) in our
study were associated with shorter survival. However, after
correction for pain, social role functioning, physical function and
general health, fatigue remained a significant predictor in only two
models. Nonetheless, if confirmed, this would strengthen the case
for further studies into the biology of post-stroke fatigue.
Our study has some weaknesses. Our data were from a
randomised trial rather than from a population-based study,
although the inclusion criteria for IST were broad. The SF-36
scores were obtained at a median of 64 weeks after stroke onset
which perhaps somewhat limits the generalisability of the findings.
The 77% response rate leads to some degree of uncertainty in the
analyses, though it is similar to the previous postal survey of fatigue
after stroke [1]. There were missing data items in some of the SF-
36 forms. We could have simplified data analysis by performing
only one analysis after excluding those with missing data, but this
might have biased our results, because non-responders may have
been systematically different from those who did respond e.g. more
depressed, more fatigued. There is no consensus about how to deal
with missing data in this type of study. Each possible method has
its own potential biases, so we dealt with these missing data items
in four different ways statistically. Reassuringly, final regression
models for SF-36 vitality were similar, and importantly, all
explained only a small amount of variance in fatigue. We were
unable to correct our analyses for levels of dependence, which is
known to influence survival [18], but we did correct for SF-36 self-
reported physical function. There were a few patients who did not
have a definite diagnosis of stroke; we decided to include these as
the physician recruiting them to IST felt that they had had a
stroke. Although fatigue is a complex experience for patients, in
large studies such as this, it is necessary to use a quick, simple tool,
such as the SF-36 vitality component, that has been validated
against a case definition for clinically significant fatigue after stroke
[11,12]. Despite these weaknesses, this very large study represents
an important new contribution to the sparse literature on fatigue
after stroke.
What are the implications of this study? Physicians should
consider mood disorders in patients with post-stroke fatigue.
Further research is required to determine the relationship between
pre-stroke and post-stroke fatigue, the natural history of fatigue
after stroke, the direction of causality between mood disorders and
fatigue and to determine whether fatigue is an independent
Table 2. Multivariate analyses showing independent
predictors of survival, according to the method of dealing
with missing SF-36 data.
Parameter Hazard ratio Lower 95% CI Upper 95% CI
Missing data set to
mean
Age 1.060 1.048 1.072
LACS 0.78 0.585 1.039
‘Other’ stroke type 4.435 1.083 18.169
PACS 0.875 0.676 1.132
POCS 0.68 0.466 0.992
Atrial fibrillation
(at randomisation)
0.708 0.555 0.904
SF-36 vitality 0.993 0.987 0.999
SF-36 social role 0.996 0.992 1.000
Missing data set
to maximum
Age 1.061 1.049 1.073
LACS 0.778 0.584 1.036
‘Other’ stroke type 4.334 1.057 17.767
PACS 0.856 0.662 1.107
POCS 0.669 0.458 0.975
Atrial fibrillation
(at randomisation)
0.694 0.544 0.885
SF-36 social role 0.994 0.991 0.997
SF-36 vitality 1.001 0.996 1.005
Missing data set
to minimum
Age 1.058 1.046 1.070
LACS 0.784 0.589 1.044
‘Other’ stroke type 4.662 1.139 19.084
PACS 0.873 0.675 1.129
POCS 0.677 0.464 0.988
Atrial fibrillation (at
randomisation)
0.710 0.556 0.905
SF-36 vitality 0.988 0.984 0.993
Missing data
excluded
Age 1.065 1.052 1.078
Atrial fibrillation
(at randomisation)
0.689 0.530 0.897
SF-36 general health 0.989 0.984 0.994
SF-36 vitality 0.994 0.988 1.001
LACS = lacunar syndrome, PACS= partial anterior circulation syndrome,
TACS = total anterior circulation syndrome, POCS = posterior circulation
syndrome.
Note that hazard ratios and 95% CI for SF-36 vitality are provided for all four
models, even though the hazard ratio reached statistical significance in only
two of the models.
doi:10.1371/journal.pone.0016988.t002
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predictor of survival and, if it is, the biological mechanism that
accounts for the survival disadvantage that fatigue confers. There
is clearly also a need to develop interventions for fatigue after
stroke and test them in appropriate trials [23].
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